Vamos a descubrirlas
GIPs action to augment splanchnic blood flow, potentially affecting nutrient uptake and its involvement in adipose tissue metabolism and suggested central affects in the regulation of appetite as seen in animal models, all remain to be further explored in humans
PLoS One 16(4):e0249738
We are excited to advance NA-931 to Phase 3 trials and provide a more comprehensive, well-tolerated treatment for obesity. Read more at: Biomed Industries presents Phase 2 results for NA-931, a new obesity treatment
Andrew Huberman notes that despite its popularity and extensive animal studies, there is only one poorly conducted human study, leaving much about its behavior in the human body, including its pharmacokinetics, still unknown 2
At Aspire Rejuvenation, we set the gold standard with twenty-three rigorously tested, clearly labeled peptide products that deliver real results without compromising your health